AbCellera Biologics Inc.
|
38.02 Million USD
|
99.75%
|
Alkermes plc
|
1.66 Billion USD
|
99.994%
|
Agenus Inc.
|
156.31 Million USD
|
99.939%
|
Aptorum Group Limited
|
431.37 Thousand USD
|
77.978%
|
Ardelyx, Inc.
|
124.45 Million USD
|
99.924%
|
Dyadic International, Inc.
|
2.89 Million USD
|
96.723%
|
Eton Pharmaceuticals, Inc.
|
31.64 Million USD
|
99.7%
|
Lantern Pharma Inc.
|
- USD
|
-Infinity%
|
Inhibikase Therapeutics, Inc.
|
260.5 Thousand USD
|
63.532%
|
Novavax, Inc.
|
983.7 Million USD
|
99.99%
|
Janux Therapeutics, Inc.
|
8.08 Million USD
|
98.825%
|
Pyxis Oncology, Inc.
|
- USD
|
-Infinity%
|
TransCode Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Ocuphire Pharma, Inc.
|
19.04 Million USD
|
99.501%
|
Outlook Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Madrigal Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
SELLAS Life Sciences Group, Inc.
|
- USD
|
-Infinity%
|
Syros Pharmaceuticals, Inc.
|
9.93 Million USD
|
99.044%
|
Barinthus Biotherapeutics plc
|
802 Thousand USD
|
88.155%
|
Windtree Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Xeris Biopharma Holdings, Inc.
|
163.91 Million USD
|
99.942%
|
Clearside Biomedical, Inc.
|
8.22 Million USD
|
98.845%
|
C4 Therapeutics, Inc.
|
20.75 Million USD
|
99.542%
|
Alnylam Pharmaceuticals, Inc.
|
1.82 Billion USD
|
99.995%
|
AlloVir, Inc.
|
- USD
|
-Infinity%
|
Arrowhead Pharmaceuticals, Inc.
|
240.73 Million USD
|
99.961%
|
VYNE Therapeutics Inc.
|
424 Thousand USD
|
77.594%
|
Bicycle Therapeutics plc
|
26.97 Million USD
|
99.648%
|
BioXcel Therapeutics, Inc.
|
1.38 Million USD
|
93.116%
|
ChromaDex Corporation
|
83.57 Million USD
|
99.886%
|
Chimerix, Inc.
|
324 Thousand USD
|
70.679%
|
Corbus Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
Caribou Biosciences, Inc.
|
34.47 Million USD
|
99.724%
|
CRISPR Therapeutics AG
|
371.2 Million USD
|
99.974%
|
Precision BioSciences, Inc.
|
48.72 Million USD
|
99.805%
|
Fate Therapeutics, Inc.
|
63.53 Million USD
|
99.85%
|
Fortress Biotech, Inc.
|
84.51 Million USD
|
99.888%
|
Fortress Biotech, Inc.
|
84.51 Million USD
|
99.888%
|
HOOKIPA Pharma Inc.
|
20.12 Million USD
|
99.528%
|
ImmuCell Corporation
|
17.47 Million USD
|
99.456%
|
IDEAYA Biosciences, Inc.
|
23.38 Million USD
|
99.594%
|
Immix Biopharma, Inc.
|
- USD
|
-Infinity%
|
Incyte Corporation
|
3.69 Billion USD
|
99.997%
|
Innoviva, Inc.
|
310.46 Million USD
|
99.969%
|
IO Biotech, Inc.
|
- USD
|
-Infinity%
|
Jaguar Health, Inc.
|
9.76 Million USD
|
99.027%
|
Keros Therapeutics, Inc.
|
151 Thousand USD
|
37.086%
|
Ligand Pharmaceuticals Incorporated
|
131.31 Million USD
|
99.928%
|
ContextLogic Inc.
|
287 Million USD
|
99.967%
|
MiMedx Group, Inc.
|
321.47 Million USD
|
99.97%
|
MEI Pharma, Inc.
|
65.29 Million USD
|
99.855%
|
NextCure, Inc.
|
- USD
|
-Infinity%
|
Onconetix, Inc.
|
58.46 Thousand USD
|
-62.49%
|
Oncternal Therapeutics, Inc.
|
785 Thousand USD
|
87.898%
|
Opthea Limited
|
261.85 Thousand USD
|
63.721%
|
Psyence Biomedical Ltd.
|
- USD
|
-Infinity%
|
Vaxcyte, Inc.
|
- USD
|
-Infinity%
|
PDS Biotechnology Corporation
|
- USD
|
-Infinity%
|
Precigen, Inc.
|
6.22 Million USD
|
98.474%
|
Pharming Group N.V.
|
245.31 Million USD
|
99.961%
|
Phathom Pharmaceuticals, Inc.
|
682 Thousand USD
|
86.07%
|
Pieris Pharmaceuticals, Inc.
|
42.81 Million USD
|
99.778%
|
PureTech Health plc
|
3.33 Million USD
|
97.147%
|
Rigel Pharmaceuticals, Inc.
|
116.88 Million USD
|
99.919%
|
Avidity Biosciences, Inc.
|
9.56 Million USD
|
99.006%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
Sangamo Therapeutics, Inc.
|
176.23 Million USD
|
99.946%
|
Sol-Gel Technologies Ltd.
|
1.55 Million USD
|
93.887%
|
Acelyrin, Inc.
|
- USD
|
-Infinity%
|
Salarius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Summit Therapeutics Inc.
|
- USD
|
-Infinity%
|
Sensei Biotherapeutics, Inc.
|
- USD
|
-Infinity%
|
Senti Biosciences, Inc.
|
2.56 Million USD
|
96.291%
|
Stoke Therapeutics, Inc.
|
8.78 Million USD
|
98.918%
|
Elevation Oncology, Inc.
|
- USD
|
-Infinity%
|
Alaunos Therapeutics, Inc.
|
5000.00 USD
|
-1800.0%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
- USD
|
-Infinity%
|
Entrada Therapeutics, Inc.
|
129.01 Million USD
|
99.926%
|
VistaGen Therapeutics, Inc.
|
1.06 Million USD
|
91.071%
|
Kintara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Wave Life Sciences Ltd.
|
113.3 Million USD
|
99.916%
|
Seer, Inc.
|
15.18 Million USD
|
99.374%
|
Verrica Pharmaceuticals Inc.
|
5.12 Million USD
|
98.146%
|
Aadi Bioscience, Inc.
|
24.35 Million USD
|
99.61%
|
ESSA Pharma Inc.
|
- USD
|
-Infinity%
|
GlycoMimetics, Inc.
|
10 Thousand USD
|
-850.0%
|
GT Biopharma, Inc.
|
- USD
|
-Infinity%
|
Inhibrx Biosciences, Inc.
|
1.8 Million USD
|
94.722%
|
Akebia Therapeutics, Inc.
|
194.62 Million USD
|
99.951%
|
Catalyst Pharmaceuticals, Inc.
|
398.2 Million USD
|
99.976%
|
Longboard Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Orchestra BioMed Holdings, Inc.
|
2.76 Million USD
|
96.558%
|
Alzamend Neuro, Inc.
|
- USD
|
-Infinity%
|
Sorrento Therapeutics, Inc.
|
62.83 Million USD
|
99.849%
|
TRACON Pharmaceuticals, Inc.
|
12.04 Million USD
|
99.211%
|
Viracta Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Rocket Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Aptose Biosciences Inc.
|
- USD
|
-Infinity%
|
ZyVersa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Soligenix, Inc.
|
839.35 Thousand USD
|
88.682%
|
Century Therapeutics, Inc.
|
2.23 Million USD
|
95.749%
|
Kura Oncology, Inc.
|
- USD
|
-Infinity%
|
TScan Therapeutics, Inc.
|
21.04 Million USD
|
99.549%
|
Intensity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Ocean Biomedical, Inc.
|
- USD
|
-Infinity%
|
CytomX Therapeutics, Inc.
|
101.21 Million USD
|
99.906%
|
Autolus Therapeutics plc
|
1.69 Million USD
|
94.405%
|
Mineralys Therapeutics, Inc.
|
- USD
|
-Infinity%
|
EyePoint Pharmaceuticals, Inc.
|
46.01 Million USD
|
99.794%
|
Eterna Therapeutics Inc.
|
68 Thousand USD
|
-39.706%
|
Adaptive Biotechnologies Corporation
|
170.27 Million USD
|
99.944%
|
GRI Bio, Inc.
|
21.76 Million USD
|
99.564%
|
Xenetic Biosciences, Inc.
|
2.53 Million USD
|
96.26%
|
Tenaya Therapeutics, Inc.
|
- USD
|
-Infinity%
|
IGM Biosciences, Inc.
|
2.13 Million USD
|
95.54%
|
INmune Bio, Inc.
|
155 Thousand USD
|
38.71%
|
Heron Therapeutics, Inc.
|
127.04 Million USD
|
99.925%
|
SAB Biotherapeutics, Inc.
|
2.23 Million USD
|
95.757%
|
Pasithea Therapeutics Corp.
|
- USD
|
-Infinity%
|
Entero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Milestone Pharmaceuticals Inc.
|
1 Million USD
|
90.5%
|
X4 Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Atara Biotherapeutics, Inc.
|
8.57 Million USD
|
98.892%
|
Coherus BioSciences, Inc.
|
257.24 Million USD
|
99.963%
|
Verastem, Inc.
|
- USD
|
-Infinity%
|
Abeona Therapeutics Inc.
|
3.5 Million USD
|
97.286%
|
Pliant Therapeutics, Inc.
|
1.58 Million USD
|
93.987%
|
Tonix Pharmaceuticals Holding Corp.
|
7.76 Million USD
|
98.777%
|
Histogen Inc.
|
3.76 Million USD
|
97.479%
|
Aprea Therapeutics, Inc.
|
583.23 Thousand USD
|
83.711%
|
Surrozen, Inc.
|
- USD
|
-Infinity%
|
Organovo Holdings, Inc.
|
109 Thousand USD
|
12.844%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
Ovid Therapeutics Inc.
|
391.69 Thousand USD
|
75.746%
|
Panbela Therapeutics, Inc.
|
- USD
|
-Infinity%
|
CASI Pharmaceuticals, Inc.
|
33.87 Million USD
|
99.72%
|
Cadrenal Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Centessa Pharmaceuticals plc
|
6.85 Million USD
|
98.614%
|
Hepion Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arcturus Therapeutics Holdings Inc.
|
157.74 Million USD
|
99.94%
|
BioRestorative Therapies, Inc.
|
145.8 Thousand USD
|
34.842%
|
Apollomics, Inc.
|
821 Thousand USD
|
88.429%
|
Amarin Corporation plc
|
306.91 Million USD
|
99.969%
|
Mesoblast Limited
|
5.9 Million USD
|
98.39%
|
Turnstone Biologics Corp.
|
19.3 Million USD
|
99.508%
|
Kymera Therapeutics, Inc.
|
78.59 Million USD
|
99.879%
|
Synaptogenix, Inc.
|
- USD
|
-Infinity%
|
Tiziana Life Sciences Ltd
|
- USD
|
-Infinity%
|
Aurinia Pharmaceuticals Inc.
|
175.51 Million USD
|
99.946%
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
Monopar Therapeutics Inc.
|
- USD
|
-Infinity%
|
Exelixis, Inc.
|
1.83 Billion USD
|
99.995%
|
Better Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Nurix Therapeutics, Inc.
|
76.98 Million USD
|
99.877%
|
Apellis Pharmaceuticals, Inc.
|
396.59 Million USD
|
99.976%
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
Dermata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Aridis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Gritstone bio, Inc.
|
1.33 Million USD
|
92.863%
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
TNF Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Avid Bioservices, Inc.
|
139.91 Million USD
|
99.932%
|
Insmed Incorporated
|
305.2 Million USD
|
99.969%
|
Virpax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
MediWound Ltd.
|
18.68 Million USD
|
99.492%
|
OmniAb, Inc.
|
34.16 Million USD
|
99.722%
|
Alector, Inc.
|
97.06 Million USD
|
99.902%
|
Seres Therapeutics, Inc.
|
126.32 Million USD
|
99.925%
|
Checkpoint Therapeutics, Inc.
|
103 Thousand USD
|
7.767%
|
Zai Lab Limited
|
266.71 Million USD
|
99.964%
|
Revance Therapeutics, Inc.
|
234.04 Million USD
|
99.959%
|
Aura Biosciences, Inc.
|
- USD
|
-Infinity%
|
Lyell Immunopharma, Inc.
|
130 Thousand USD
|
26.923%
|
Immunic, Inc.
|
- USD
|
-Infinity%
|
Tarsus Pharmaceuticals, Inc.
|
17.44 Million USD
|
99.455%
|
Veracyte, Inc.
|
361.05 Million USD
|
99.974%
|
InMed Pharmaceuticals Inc.
|
4.59 Million USD
|
97.934%
|
FibroGen, Inc.
|
147.75 Million USD
|
99.936%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
Adial Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sonnet BioTherapeutics Holdings, Inc.
|
147.8 Thousand USD
|
35.726%
|
Jazz Pharmaceuticals plc
|
3.83 Billion USD
|
99.998%
|
Cyclacel Pharmaceuticals, Inc.
|
420 Thousand USD
|
77.381%
|
Amylyx Pharmaceuticals, Inc.
|
380.78 Million USD
|
99.975%
|
TG Therapeutics, Inc.
|
233.66 Million USD
|
99.959%
|
Galecto, Inc.
|
- USD
|
-Infinity%
|
Calithera Biosciences, Inc.
|
- USD
|
-Infinity%
|
Fortrea Holdings Inc.
|
3.1 Billion USD
|
99.997%
|
KalVista Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Aptevo Therapeutics Inc.
|
- USD
|
-Infinity%
|
XBiotech Inc.
|
- USD
|
-Infinity%
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Lyra Therapeutics, Inc.
|
1.55 Million USD
|
93.902%
|
Foghorn Therapeutics Inc.
|
34.15 Million USD
|
99.722%
|
Y-mAbs Therapeutics, Inc.
|
84.81 Million USD
|
99.888%
|
Theravance Biopharma, Inc.
|
57.42 Million USD
|
99.835%
|
Ultragenyx Pharmaceutical Inc.
|
434.24 Million USD
|
99.978%
|
Metagenomi, Inc. Common Stock
|
44.75 Million USD
|
99.788%
|
Vaxxinity, Inc.
|
- USD
|
-Infinity%
|
BioCryst Pharmaceuticals, Inc.
|
331.41 Million USD
|
99.971%
|
Gain Therapeutics, Inc.
|
55.18 Thousand USD
|
-72.164%
|
Cartesian Therapeutics, Inc.
|
26 Million USD
|
99.635%
|
NexImmune, Inc.
|
- USD
|
-Infinity%
|
Creative Medical Technology Holdings, Inc.
|
9000.00 USD
|
-955.556%
|
Marker Therapeutics, Inc.
|
3.31 Million USD
|
97.131%
|
Regeneron Pharmaceuticals, Inc.
|
13.11 Billion USD
|
99.999%
|
Chemomab Therapeutics Ltd.
|
- USD
|
-Infinity%
|
Scopus BioPharma Inc.
|
- USD
|
-Infinity%
|
RAPT Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Ainos, Inc.
|
122.11 Thousand USD
|
22.203%
|
Pluri Inc.
|
326 Thousand USD
|
70.859%
|
Prothena Corporation plc
|
91.37 Million USD
|
99.896%
|
Adaptimmune Therapeutics plc
|
60.28 Million USD
|
99.842%
|
Celularity Inc.
|
22.77 Million USD
|
99.583%
|
Rallybio Corporation
|
- USD
|
-Infinity%
|
Cue Biopharma, Inc.
|
5.49 Million USD
|
98.27%
|
MeiraGTx Holdings plc
|
14.01 Million USD
|
99.322%
|
Omeros Corporation
|
- USD
|
-Infinity%
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
Immunocore Holdings plc
|
249.42 Million USD
|
99.962%
|
Cocrystal Pharma, Inc.
|
- USD
|
-Infinity%
|
Cidara Therapeutics, Inc.
|
63.9 Million USD
|
99.851%
|
Blueprint Medicines Corporation
|
249.38 Million USD
|
99.962%
|
CalciMedica, Inc.
|
- USD
|
-Infinity%
|
Cabaletta Bio, Inc.
|
- USD
|
-Infinity%
|
Marinus Pharmaceuticals, Inc.
|
30.98 Million USD
|
99.693%
|
Scholar Rock Holding Corporation
|
- USD
|
-Infinity%
|
Sana Biotechnology, Inc.
|
- USD
|
-Infinity%
|
Pulmatrix, Inc.
|
7.29 Million USD
|
98.698%
|
Elicio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Vigil Neuroscience, Inc.
|
- USD
|
-Infinity%
|
Intellia Therapeutics, Inc.
|
36.27 Million USD
|
99.738%
|
Adlai Nortye Ltd. American Depositary Shares
|
4.99 Million USD
|
98.098%
|
Cytokinetics, Incorporated
|
7.53 Million USD
|
98.738%
|
Eloxx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Nutriband Inc.
|
2.08 Million USD
|
95.444%
|
Protara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Vor Biopharma Inc.
|
- USD
|
-Infinity%
|
Roivant Sciences Ltd.
|
124.79 Million USD
|
99.924%
|
Evogene Ltd.
|
5.64 Million USD
|
98.316%
|
ProKidney Corp.
|
- USD
|
-Infinity%
|
Applied Therapeutics, Inc.
|
9.99 Million USD
|
99.049%
|
Hoth Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BridgeBio Pharma, Inc.
|
9.3 Million USD
|
98.979%
|
CorMedix Inc.
|
- USD
|
-Infinity%
|
BioLineRx Ltd.
|
4.8 Million USD
|
98.021%
|
Tango Therapeutics, Inc.
|
36.52 Million USD
|
99.74%
|
Galectin Therapeutics Inc.
|
- USD
|
-Infinity%
|
Atai Life Sciences N.V.
|
314 Thousand USD
|
69.745%
|
Renovaro Biosciences Inc.
|
- USD
|
-Infinity%
|
Aerovate Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Zentalis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sagimet Biosciences Inc.
|
2 Million USD
|
95.25%
|
MediciNova, Inc.
|
1 Million USD
|
90.5%
|
Praxis Precision Medicines, Inc.
|
2.44 Million USD
|
96.118%
|
Cardio Diagnostics Holdings, Inc.
|
17.06 Thousand USD
|
-456.695%
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
Axsome Therapeutics, Inc.
|
270.6 Million USD
|
99.965%
|
Biomea Fusion, Inc.
|
- USD
|
-Infinity%
|
PTC Therapeutics, Inc.
|
937.82 Million USD
|
99.99%
|
Mereo BioPharma Group plc
|
10 Million USD
|
99.05%
|
Cullinan Oncology, Inc.
|
- USD
|
-Infinity%
|
Syndax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Absci Corporation
|
5.71 Million USD
|
98.339%
|
NRx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
4D Molecular Therapeutics, Inc.
|
20.72 Million USD
|
99.542%
|
Dyne Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Kiniksa Pharmaceuticals, Ltd.
|
270.25 Million USD
|
99.965%
|
Ventyx Biosciences, Inc.
|
- USD
|
-Infinity%
|
Allakos Inc.
|
- USD
|
-Infinity%
|
Imunon, Inc.
|
- USD
|
-Infinity%
|
Fulcrum Therapeutics, Inc.
|
2.8 Million USD
|
96.613%
|
Corcept Therapeutics Incorporated
|
482.37 Million USD
|
99.98%
|
BioAtla, Inc.
|
- USD
|
-Infinity%
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
Bio-Path Holdings, Inc.
|
- USD
|
-Infinity%
|
Larimar Therapeutics, Inc.
|
- USD
|
-Infinity%
|
XOMA Corporation
|
4.75 Million USD
|
98.003%
|
Kezar Life Sciences, Inc.
|
7 Million USD
|
98.643%
|
Cara Therapeutics, Inc.
|
20.96 Million USD
|
99.547%
|
aTyr Pharma, Inc.
|
353 Thousand USD
|
73.088%
|
Aligos Therapeutics, Inc.
|
15.52 Million USD
|
99.388%
|
Akero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Viridian Therapeutics, Inc.
|
314 Thousand USD
|
69.745%
|
Eliem Therapeutics, Inc.
|
- USD
|
-Infinity%
|
EyeGate Pharmaceuticals, Inc.
|
12.05 Thousand USD
|
-687.793%
|
Akari Therapeutics, Plc
|
- USD
|
-Infinity%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
Halozyme Therapeutics, Inc.
|
829.25 Million USD
|
99.989%
|
Lexaria Bioscience Corp.
|
226.2 Thousand USD
|
58.003%
|
UroGen Pharma Ltd.
|
82.71 Million USD
|
99.885%
|
Sutro Biopharma, Inc.
|
153.73 Million USD
|
99.938%
|
ZIVO Bioscience, Inc.
|
27.65 Thousand USD
|
-243.58%
|
Orgenesis Inc.
|
530 Thousand USD
|
82.075%
|
Entera Bio Ltd.
|
- USD
|
-Infinity%
|
GH Research PLC
|
- USD
|
-Infinity%
|
Lisata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Reneo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Xencor, Inc.
|
168.33 Million USD
|
99.944%
|
60 Degrees Pharmaceuticals, Inc.
|
253.57 Thousand USD
|
62.535%
|
Replimune Group, Inc.
|
- USD
|
-Infinity%
|
Coeptis Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Vanda Pharmaceuticals Inc.
|
192.64 Million USD
|
99.951%
|
Lexaria Bioscience Corp.
|
226.2 Thousand USD
|
58.003%
|
Portage Biotech Inc.
|
- USD
|
-Infinity%
|
Cardio Diagnostics Holdings, Inc.
|
17.06 Thousand USD
|
-456.695%
|
Olema Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
OncoCyte Corporation
|
1.5 Million USD
|
93.679%
|
Qualigen Therapeutics, Inc.
|
5.2 Million USD
|
98.175%
|
Processa Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Purple Biotech Ltd.
|
- USD
|
-Infinity%
|
CollPlant Biotechnologies Ltd.
|
10.95 Million USD
|
99.133%
|
scPharmaceuticals Inc.
|
13.59 Million USD
|
99.301%
|
ProMIS Neurosciences, Inc.
|
- USD
|
-Infinity%
|
HilleVax, Inc.
|
- USD
|
-Infinity%
|
NeuroSense Therapeutics Ltd.
|
- USD
|
-Infinity%
|
Tharimmune, Inc.
|
- USD
|
-Infinity%
|
Genprex, Inc.
|
- USD
|
-Infinity%
|
Neumora Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Atossa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
XTL Biopharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
Virios Therapeutics, Inc.
|
- USD
|
-Infinity%
|
OKYO Pharma Limited
|
- USD
|
-Infinity%
|
Savara Inc.
|
- USD
|
-Infinity%
|
Curis, Inc.
|
10.02 Million USD
|
99.052%
|
Daré Bioscience, Inc.
|
2.8 Million USD
|
96.617%
|
Carmell Therapeutics Corporation
|
- USD
|
-Infinity%
|
Titan Pharmaceuticals, Inc.
|
184 Thousand USD
|
48.37%
|
Achieve Life Sciences, Inc.
|
- USD
|
-Infinity%
|
BeiGene, Ltd.
|
2.45 Billion USD
|
99.996%
|
Kiromic BioPharma, Inc.
|
- USD
|
-Infinity%
|
Revolution Medicines, Inc. Warrant
|
11.58 Million USD
|
99.18%
|
Protagonist Therapeutics, Inc.
|
60 Million USD
|
99.842%
|
Erasca, Inc.
|
- USD
|
-Infinity%
|
bluebird bio, Inc.
|
29.49 Million USD
|
99.678%
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BioMarin Pharmaceutical Inc.
|
2.41 Billion USD
|
99.996%
|
DBV Technologies S.A.
|
15.72 Million USD
|
99.396%
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Moderna, Inc.
|
6.84 Billion USD
|
99.999%
|
Vincerx Pharma, Inc.
|
- USD
|
-Infinity%
|
Fresh Tracks Therapeutics, Inc.
|
8 Million USD
|
98.813%
|
Molecular Templates, Inc.
|
57.3 Million USD
|
99.834%
|
Acrivon Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Travere Therapeutics, Inc.
|
145.23 Million USD
|
99.935%
|
Monte Rosa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Spruce Biosciences, Inc.
|
10.08 Million USD
|
99.058%
|
Celldex Therapeutics, Inc.
|
6.88 Million USD
|
98.62%
|
Cogent Biosciences, Inc.
|
- USD
|
-Infinity%
|
MacroGenics, Inc.
|
58.74 Million USD
|
99.838%
|
RenovoRx, Inc.
|
- USD
|
-Infinity%
|
Adicet Bio, Inc.
|
- USD
|
-Infinity%
|
Prime Medicine, Inc.
|
- USD
|
-Infinity%
|
Aditxt, Inc.
|
645.17 Thousand USD
|
85.275%
|
Adagene Inc.
|
18.11 Million USD
|
99.475%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
Quantum-Si incorporated
|
1.08 Million USD
|
91.22%
|
Maravai LifeSciences Holdings, Inc.
|
288.94 Million USD
|
99.967%
|
Acurx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Voyager Therapeutics, Inc.
|
250 Million USD
|
99.962%
|
SciSparc Ltd.
|
2.87 Million USD
|
96.7%
|
Vericel Corporation
|
197.51 Million USD
|
99.952%
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
Minerva Neurosciences, Inc.
|
- USD
|
-Infinity%
|
Generation Bio Co.
|
5.9 Million USD
|
98.391%
|
Astria Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Black Diamond Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Arcutis Biotherapeutics, Inc.
|
59.6 Million USD
|
99.841%
|
Invivyd, Inc.
|
- USD
|
-Infinity%
|
Relay Therapeutics, Inc.
|
25.54 Million USD
|
99.628%
|
Quoin Pharmaceuticals, Ltd.
|
- USD
|
-Infinity%
|
Spero Therapeutics, Inc.
|
96.73 Million USD
|
99.902%
|
Artelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
2seventy bio, Inc.
|
100.38 Million USD
|
99.905%
|
ADMA Biologics, Inc.
|
258.21 Million USD
|
99.963%
|
Clene Inc.
|
654 Thousand USD
|
85.474%
|
Capricor Therapeutics, Inc.
|
25.17 Million USD
|
99.623%
|
Boundless Bio, Inc. Common Stock
|
- USD
|
-Infinity%
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
Recursion Pharmaceuticals, Inc.
|
44.57 Million USD
|
99.787%
|
Citius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
50 Million USD
|
99.81%
|
Relmada Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Finch Therapeutics Group, Inc.
|
107 Thousand USD
|
11.215%
|
ALX Oncology Holdings Inc.
|
- USD
|
-Infinity%
|
Vir Biotechnology, Inc.
|
86.18 Million USD
|
99.89%
|
Evaxion Biotech A/S
|
73.11 Thousand USD
|
-29.938%
|
Ocular Therapeutix, Inc.
|
58.44 Million USD
|
99.837%
|
Verve Therapeutics, Inc.
|
11.75 Million USD
|
99.192%
|
Trevena, Inc.
|
3.12 Million USD
|
96.96%
|
Surrozen, Inc.
|
- USD
|
-Infinity%
|
Tyra Biosciences, Inc.
|
- USD
|
-Infinity%
|
Cingulate Inc.
|
- USD
|
-Infinity%
|
Galmed Pharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
Unity Biotechnology, Inc.
|
- USD
|
-Infinity%
|
Tenax Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Terns Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
ACADIA Pharmaceuticals Inc.
|
726.43 Million USD
|
99.987%
|
Connect Biopharma Holdings Limited
|
- USD
|
-Infinity%
|
Clearmind Medicine Inc.
|
- USD
|
-Infinity%
|
Kronos Bio, Inc.
|
6.28 Million USD
|
98.489%
|
Bolt Biotherapeutics, Inc.
|
7.87 Million USD
|
98.794%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Viking Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Statera Biopharma, Inc.
|
- USD
|
-Infinity%
|
ImmunityBio, Inc.
|
622 Thousand USD
|
84.727%
|
Korro Bio, Inc.
|
- USD
|
-Infinity%
|
Kineta, Inc.
|
5.44 Million USD
|
98.254%
|
BioVie Inc.
|
- USD
|
-Infinity%
|
Codexis, Inc.
|
70.14 Million USD
|
99.865%
|
Celularity Inc.
|
22.77 Million USD
|
99.583%
|
Crinetics Pharmaceuticals, Inc.
|
4.01 Million USD
|
97.633%
|
Celcuity Inc.
|
- USD
|
-Infinity%
|
Virax Biolabs Group Limited
|
156.41 Thousand USD
|
39.266%
|
Cibus, Inc.
|
1.81 Million USD
|
94.772%
|
Eledon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
eFFECTOR Therapeutics, Inc.
|
- USD
|
-Infinity%
|
IN8bio, Inc.
|
- USD
|
-Infinity%
|
Kodiak Sciences Inc.
|
- USD
|
-Infinity%
|
Annexon, Inc.
|
- USD
|
-Infinity%
|
Adverum Biotechnologies, Inc.
|
3.6 Million USD
|
97.361%
|
Assembly Biosciences, Inc.
|
7.16 Million USD
|
98.674%
|
Avalo Therapeutics, Inc.
|
1.92 Million USD
|
95.062%
|
Ionis Pharmaceuticals, Inc.
|
787.64 Million USD
|
99.988%
|
Eyenovia, Inc.
|
3787.00 USD
|
-2408.582%
|
Puma Biotechnology, Inc.
|
235.63 Million USD
|
99.96%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Xilio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Arcellx, Inc.
|
110.31 Million USD
|
99.914%
|
Cardiff Oncology, Inc.
|
488 Thousand USD
|
80.533%
|
Enanta Pharmaceuticals, Inc.
|
79.2 Million USD
|
99.88%
|
Regulus Therapeutics Inc.
|
- USD
|
-Infinity%
|
Moolec Science SA
|
905.04 Thousand USD
|
89.503%
|
Acumen Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Geron Corporation
|
237 Thousand USD
|
59.916%
|
LAVA Therapeutics N.V.
|
6.76 Million USD
|
98.597%
|
Royalty Pharma plc
|
2.35 Billion USD
|
99.996%
|
Atea Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Greenwich LifeSciences, Inc.
|
- USD
|
-Infinity%
|
TFF Pharmaceuticals, Inc.
|
733.87 Thousand USD
|
87.055%
|
Mersana Therapeutics, Inc.
|
36.85 Million USD
|
99.742%
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
Structure Therapeutics Inc.
|
- USD
|
-Infinity%
|
89bio, Inc.
|
- USD
|
-Infinity%
|
PMV Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Avenue Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Genelux Corporation
|
170 Thousand USD
|
44.118%
|
Trevi Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Lexicon Pharmaceuticals, Inc.
|
1.2 Million USD
|
92.11%
|
Notable Labs, Ltd.
|
310 Thousand USD
|
69.355%
|
Liquidia Corporation
|
17.48 Million USD
|
99.457%
|
Mustang Bio, Inc.
|
- USD
|
-Infinity%
|
Immunovant, Inc.
|
- USD
|
-Infinity%
|
Quantum-Si incorporated
|
1.08 Million USD
|
91.22%
|
Arbutus Biopharma Corporation
|
18.14 Million USD
|
99.476%
|
DiaMedica Therapeutics Inc.
|
- USD
|
-Infinity%
|
Vera Therapeutics, Inc.
|
1.86 Million USD
|
94.898%
|
Acasti Pharma Inc.
|
- USD
|
-Infinity%
|
MiNK Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Pasithea Therapeutics Corp.
|
- USD
|
-Infinity%
|
Xenon Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Elevai Labs, Inc. Common Stock
|
1.71 Million USD
|
94.453%
|
NeuroBo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Tempest Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Soleno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
PepGen Inc.
|
- USD
|
-Infinity%
|
Moleculin Biotech, Inc.
|
- USD
|
-Infinity%
|
United Therapeutics Corporation
|
2.32 Billion USD
|
99.996%
|
Nuvectis Pharma, Inc.
|
- USD
|
-Infinity%
|
Solid Biosciences Inc.
|
- USD
|
-Infinity%
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
Immuneering Corporation
|
- USD
|
-Infinity%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
Silo Pharma, Inc.
|
72.1 Thousand USD
|
-31.758%
|
Belite Bio, Inc
|
- USD
|
-Infinity%
|
XOMA Corporation
|
4.75 Million USD
|
98.003%
|
ARS Pharmaceuticals, Inc.
|
30 Thousand USD
|
-216.667%
|
Bionomics Limited
|
- USD
|
-Infinity%
|
Apogee Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
uniQure N.V.
|
15.84 Million USD
|
99.4%
|
Cassava Sciences, Inc.
|
- USD
|
-Infinity%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
Poseida Therapeutics, Inc.
|
64.7 Million USD
|
99.853%
|
Forte Biosciences, Inc.
|
- USD
|
-Infinity%
|
Anebulo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Enlivex Therapeutics Ltd.
|
- USD
|
-Infinity%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
FibroBiologics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Altimmune, Inc.
|
426 Thousand USD
|
77.7%
|
Amicus Therapeutics, Inc.
|
399.35 Million USD
|
99.976%
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
Compugen Ltd.
|
33.45 Million USD
|
99.716%
|
Peak Bio, Inc.
|
367.87 Thousand USD
|
74.176%
|
Zevra Therapeutics, Inc.
|
27.46 Million USD
|
99.654%
|
Benitec Biopharma Inc.
|
216 Thousand USD
|
56.019%
|
Spyre Therapeutics, Inc.
|
886 Thousand USD
|
89.278%
|
NKGen Biotech, Inc. Common Stock
|
- USD
|
-Infinity%
|
Zura Bio Limited
|
- USD
|
-Infinity%
|
PolyPid Ltd.
|
- USD
|
-Infinity%
|
Aileron Therapeutics, Inc.
|
- USD
|
-Infinity%
|
NKGen Biotech, Inc. Warrants
|
- USD
|
-Infinity%
|
Instil Bio, Inc.
|
- USD
|
-Infinity%
|
argenx SE
|
1.22 Billion USD
|
99.992%
|
Immunome, Inc.
|
14.01 Million USD
|
99.322%
|
Compass Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Verona Pharma plc
|
- USD
|
-Infinity%
|
enGene Holdings Inc. Warrants
|
- USD
|
-Infinity%
|
Shattuck Labs, Inc.
|
1.65 Million USD
|
94.267%
|
CervoMed Inc.
|
7.14 Million USD
|
98.67%
|
LENZ Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Plus Therapeutics, Inc.
|
4.91 Million USD
|
98.066%
|
Dianthus Therapeutics, Inc.
|
2.82 Million USD
|
96.638%
|
Moolec Science SA
|
905.04 Thousand USD
|
89.503%
|
Enveric Biosciences, Inc.
|
- USD
|
-Infinity%
|
Inovio Pharmaceuticals, Inc.
|
832.01 Thousand USD
|
88.582%
|
AnaptysBio, Inc.
|
17.15 Million USD
|
99.446%
|
Design Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Leap Therapeutics, Inc.
|
- USD
|
-Infinity%
|
NeurAxis, Inc.
|
2.46 Million USD
|
96.138%
|
Seelos Therapeutics, Inc.
|
2.2 Million USD
|
95.688%
|
Lumos Pharma, Inc.
|
2.05 Million USD
|
95.368%
|
Achilles Therapeutics plc
|
- USD
|
-Infinity%
|
enGene Holdings Inc. Common Stock
|
- USD
|
-Infinity%
|
180 Life Sciences Corp.
|
- USD
|
-Infinity%
|
Opiant Pharmaceuticals, Inc.
|
40.72 Million USD
|
99.767%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Nutriband Inc.
|
2.08 Million USD
|
95.444%
|
ORIC Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
CG Oncology, Inc. Common stock
|
204 Thousand USD
|
53.431%
|
Fractyl Health, Inc. Common Stock
|
120 Thousand USD
|
20.833%
|
Rani Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
MoonLake Immunotherapeutics
|
- USD
|
-Infinity%
|
Palisade Bio, Inc.
|
250 Thousand USD
|
62.0%
|
Tourmaline Bio, Inc.
|
- USD
|
-Infinity%
|
Beam Therapeutics Inc.
|
377.7 Million USD
|
99.975%
|
Neurogene Inc.
|
- USD
|
-Infinity%
|
Mirum Pharmaceuticals, Inc.
|
186.37 Million USD
|
99.949%
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
CARGO Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Sesen Bio, Inc.
|
40 Million USD
|
99.763%
|
Enliven Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Kiora Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Iovance Biotherapeutics, Inc.
|
1.18 Million USD
|
92.01%
|
Taysha Gene Therapies, Inc.
|
15.45 Million USD
|
99.385%
|
Athira Pharma, Inc.
|
- USD
|
-Infinity%
|
Vaccinex, Inc.
|
570 Thousand USD
|
83.333%
|
HCW Biologics Inc.
|
2.84 Million USD
|
96.657%
|
XOMA Corporation
|
4.75 Million USD
|
98.003%
|
Nektar Therapeutics
|
90.12 Million USD
|
99.895%
|
Arvinas, Inc.
|
78.5 Million USD
|
99.879%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
Merus N.V.
|
43.94 Million USD
|
99.784%
|
Omega Therapeutics, Inc.
|
3.09 Million USD
|
96.93%
|
Quince Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Rezolute, Inc.
|
- USD
|
-Infinity%
|
Clene Inc.
|
654 Thousand USD
|
85.474%
|
Indaptus Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BeyondSpring Inc.
|
1.75 Million USD
|
94.575%
|
Synlogic, Inc.
|
3.37 Million USD
|
97.182%
|
Allarity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Phio Pharmaceuticals Corp.
|
- USD
|
-Infinity%
|
Peak Bio, Inc.
|
367.87 Thousand USD
|
74.176%
|
Werewolf Therapeutics, Inc.
|
19.94 Million USD
|
99.524%
|
Krystal Biotech, Inc.
|
50.69 Million USD
|
99.813%
|
Karyopharm Therapeutics Inc.
|
146.03 Million USD
|
99.935%
|
SpringWorks Therapeutics, Inc.
|
5.44 Million USD
|
98.256%
|
Lipella Pharmaceuticals Inc.
|
449.61 Thousand USD
|
78.871%
|
MannKind Corporation
|
198.96 Million USD
|
99.952%
|
Ikena Oncology, Inc.
|
9.16 Million USD
|
98.963%
|
Cyclerion Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Gyre Therapeutics, Inc.
|
113.45 Million USD
|
99.916%
|
Gossamer Bio, Inc.
|
- USD
|
-Infinity%
|
CohBar, Inc.
|
- USD
|
-Infinity%
|
Cognition Therapeutics, Inc.
|
- USD
|
-Infinity%
|
NRx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Legend Biotech Corporation
|
285.14 Million USD
|
99.967%
|
Mural Oncology plc
|
- USD
|
-Infinity%
|
Biora Therapeutics, Inc.
|
4000.00 USD
|
-2275.0%
|
PaxMedica, Inc. Common Stock
|
- USD
|
-Infinity%
|
Disc Medicine, Inc.
|
- USD
|
-Infinity%
|
Champions Oncology, Inc.
|
50.15 Million USD
|
99.811%
|
REGENXBIO Inc.
|
90.24 Million USD
|
99.895%
|
Ensysce Biosciences, Inc.
|
2.23 Million USD
|
95.741%
|
Anavex Life Sciences Corp.
|
- USD
|
-Infinity%
|
Cellectar Biosciences, Inc.
|
- USD
|
-Infinity%
|
Edgewise Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Vaxart, Inc.
|
7.37 Million USD
|
98.713%
|
PharmaCyte Biotech, Inc.
|
- USD
|
-Infinity%
|
Aldeyra Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Cellectis S.A.
|
755 Thousand USD
|
87.417%
|
Longeveron Inc.
|
709 Thousand USD
|
86.601%
|
Repare Therapeutics Inc.
|
51.13 Million USD
|
99.814%
|
Sarepta Therapeutics, Inc.
|
1.24 Billion USD
|
99.992%
|
Inozyme Pharma, Inc.
|
- USD
|
-Infinity%
|
Revolution Medicines, Inc.
|
11.58 Million USD
|
99.18%
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
Third Harmonic Bio, Inc.
|
- USD
|
-Infinity%
|
ArriVent BioPharma, Inc. Common Stock
|
- USD
|
-Infinity%
|
AN2 Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Anixa Biosciences, Inc.
|
210 Thousand USD
|
54.762%
|
Vertex Pharmaceuticals Incorporated
|
9.86 Billion USD
|
99.999%
|
Denali Therapeutics Inc.
|
330.53 Million USD
|
99.971%
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
Veru Inc.
|
16.29 Million USD
|
99.417%
|
Corvus Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Cingulate Inc.
|
- USD
|
-Infinity%
|
Passage Bio, Inc.
|
- USD
|
-Infinity%
|
Context Therapeutics Inc.
|
- USD
|
-Infinity%
|
Exicure, Inc.
|
- USD
|
-Infinity%
|
Day One Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Oramed Pharmaceuticals Inc.
|
2.7 Million USD
|
96.485%
|
Scinai Immunotherapeutics Ltd.
|
- USD
|
-Infinity%
|
Rhythm Pharmaceuticals, Inc.
|
77.42 Million USD
|
99.877%
|
Nuvalent, Inc.
|
- USD
|
-Infinity%
|
ABVC BioPharma, Inc.
|
152.43 Thousand USD
|
37.676%
|
Carisma Therapeutics, Inc.
|
14.91 Million USD
|
99.363%
|
Unicycive Therapeutics, Inc.
|
675 Thousand USD
|
85.926%
|
OmniAb, Inc.
|
34.16 Million USD
|
99.722%
|
Anew Medical, Inc.
|
- USD
|
-Infinity%
|
Fennec Pharmaceuticals Inc.
|
21.25 Million USD
|
99.553%
|
Lipocine Inc.
|
-2.85 Million USD
|
103.332%
|
Lexeo Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Nautilus Biotechnology, Inc.
|
- USD
|
-Infinity%
|
SAB Biotherapeutics, Inc.
|
2.23 Million USD
|
95.757%
|
G1 Therapeutics, Inc.
|
82.51 Million USD
|
99.885%
|
Bellerophon Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Sage Therapeutics, Inc.
|
86.45 Million USD
|
99.89%
|
Ocugen, Inc.
|
6.03 Million USD
|
98.426%
|
Mind Medicine (MindMed) Inc.
|
- USD
|
-Infinity%
|
Q32 Bio Inc.
|
1.15 Million USD
|
91.782%
|
Brainstorm Cell Therapeutics Inc.
|
- USD
|
-Infinity%
|
Alumis Inc. Common Stock
|
- USD
|
-Infinity%
|
Equillium, Inc.
|
36.08 Million USD
|
99.737%
|
Kyverna Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Coya Therapeutics, Inc.
|
6 Million USD
|
98.417%
|
CNS Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Galera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Evelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
Comera Life Sciences Holdings, Inc.
|
633.1 Thousand USD
|
84.995%
|
Dominari Holdings Inc.
|
2.03 Million USD
|
95.341%
|
Edesa Biotech, Inc.
|
- USD
|
-Infinity%
|
vTv Therapeutics Inc.
|
- USD
|
-Infinity%
|
Bio-Techne Corporation
|
1.15 Billion USD
|
99.992%
|
Agios Pharmaceuticals, Inc.
|
26.82 Million USD
|
99.646%
|
Harmony Biosciences Holdings, Inc.
|
582.02 Million USD
|
99.984%
|
Prelude Therapeutics Incorporated
|
- USD
|
-Infinity%
|
Candel Therapeutics, Inc.
|
- USD
|
-Infinity%
|
iTeos Therapeutics, Inc.
|
12.59 Million USD
|
99.246%
|
Nkarta, Inc.
|
- USD
|
-Infinity%
|
BioCardia, Inc.
|
477 Thousand USD
|
80.084%
|
Iterum Therapeutics plc
|
- USD
|
-Infinity%
|